A novel neuroimmune modulation system for the treatment of rheumatoid arthritis
© 2024. The Author(s)..
The vagus nerve has an anti-inflammatory effect through the inflammatory reflex, which inhibits the release of proinflammatory cytokines by macrophages. Recent pilot clinical trials, using implantable bioelectronic devices, have demonstrated the efficacy of vagus nerve stimulation in adult patients with rheumatoid arthritis and inflammatory bowel diseases as an alternative to drugs, which are not devoid of side effects and are costly. In this issue of Bioelectronic Medicine, Peterson et al. report the safety of novel implantable neuroimmune modulation device for treating rheumatoid arthritis (The RESET RA study), which I will discuss in this commentary.
| Errataetall: |
CommentOn: Bioelectron Med. 2024 Mar 13;10(1):8. - PMID 38475923 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Bioelectronic medicine - 10(2024), 1 vom: 03. Apr., Seite 9 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bonaz, Bruno [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cholinergic anti-inflammatory pathway |
|---|
| Anmerkungen: |
Date Revised 05.04.2024 published: Electronic CommentOn: Bioelectron Med. 2024 Mar 13;10(1):8. - PMID 38475923 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1186/s42234-024-00142-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370556526 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370556526 | ||
| 003 | DE-627 | ||
| 005 | 20240405234112.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240404s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s42234-024-00142-9 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1366.xml |
| 035 | |a (DE-627)NLM370556526 | ||
| 035 | |a (NLM)38566215 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bonaz, Bruno |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A novel neuroimmune modulation system for the treatment of rheumatoid arthritis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 05.04.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a CommentOn: Bioelectron Med. 2024 Mar 13;10(1):8. - PMID 38475923 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2024. The Author(s). | ||
| 520 | |a The vagus nerve has an anti-inflammatory effect through the inflammatory reflex, which inhibits the release of proinflammatory cytokines by macrophages. Recent pilot clinical trials, using implantable bioelectronic devices, have demonstrated the efficacy of vagus nerve stimulation in adult patients with rheumatoid arthritis and inflammatory bowel diseases as an alternative to drugs, which are not devoid of side effects and are costly. In this issue of Bioelectronic Medicine, Peterson et al. report the safety of novel implantable neuroimmune modulation device for treating rheumatoid arthritis (The RESET RA study), which I will discuss in this commentary | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a Cholinergic anti-inflammatory pathway | |
| 650 | 4 | |a Inflammatory bowel diseases | |
| 650 | 4 | |a Rheumatoid arthritis | |
| 650 | 4 | |a Vagus nerve | |
| 650 | 4 | |a Vagus nerve stimulation | |
| 773 | 0 | 8 | |i Enthalten in |t Bioelectronic medicine |d 2015 |g 10(2024), 1 vom: 03. Apr., Seite 9 |w (DE-627)NLM253922461 |x 2332-8886 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2024 |g number:1 |g day:03 |g month:04 |g pages:9 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s42234-024-00142-9 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2024 |e 1 |b 03 |c 04 |h 9 | ||